| Head and Neck Carcinoma of Unknown Primary studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245682early Phase 1 · active not recruiting Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995508Phase 2 · recruiting Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567422Phase 1 · active not recruiting Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754321Phase 1 · recruiting Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538510Phase 1/Phase 2 · completed Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · condition mapped ALIAS · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04489212NA · completed Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries · condition mapped ONTOLOGY_EXACT · 16 trials mapped (10 active) | — | — | Head and Neck Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped ALIAS · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196168Phase 2 · terminated Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ALIAS · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped ALIAS · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped ALIAS · 16 trials mapped (10 active) | — | — | Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |